Mark B. Orringer

30.2k total citations · 5 hit papers
267 papers, 17.4k citations indexed

About

Mark B. Orringer is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Mark B. Orringer has authored 267 papers receiving a total of 17.4k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Surgery, 136 papers in Pulmonary and Respiratory Medicine and 42 papers in Molecular Biology. Recurrent topics in Mark B. Orringer's work include Esophageal Cancer Research and Treatment (97 papers), Esophageal and GI Pathology (90 papers) and Lung Cancer Diagnosis and Treatment (40 papers). Mark B. Orringer is often cited by papers focused on Esophageal Cancer Research and Treatment (97 papers), Esophageal and GI Pathology (90 papers) and Lung Cancer Diagnosis and Treatment (40 papers). Mark B. Orringer collaborates with scholars based in United States, China and Australia. Mark B. Orringer's co-authors include Mark D. Iannettoni, David G. Beer, Herbert Sloan, Becky Marshall, Mack C. Stirling, Andrew C. Chang, Thomas J. Giordano, Richard I. Whyte, Arlene A. Forastiere and Susan G. Urba and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Mark B. Orringer

263 papers receiving 16.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene-expression profiles predict survival of patients with lung adenocarcinoma

2002 1.5k citations David G. Beer, Thomas J. Giordano et al. profile →
Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal Carcinoma

2001 967 citations Mark B. Orringer et al. profile →
Discordant Protein and mRNA Expression in Lung Adenocarcinomas

2002 790 citations Guoan Chen, Thomas J. Giordano et al. profile →
Transhiatal Esophagectomy: Clinical Experience and Refinements

1999 455 citations Mark B. Orringer et al. profile →
Esophagectomy without thoracotomy

1978 359 citations Mark B. Orringer, Herbert Sloan Journal of Thoracic and Cardiovascular Surgery profile →

Peers

Countries citing papers authored by Mark B. Orringer

Since Specialization

Citations

This map shows the geographic impact of Mark B. Orringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Orringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Orringer more than expected).

Fields of papers citing papers by Mark B. Orringer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark B. Orringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Orringer. The network helps show where Mark B. Orringer may publish in the future.

Co-authorship network of co-authors of Mark B. Orringer

This figure shows the co-authorship network connecting the top 25 collaborators of Mark B. Orringer. A scholar is included among the top collaborators of Mark B. Orringer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark B. Orringer. Mark B. Orringer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Phase II Randomized Trial of Radical Resection vs. Stereotactic Body Radiation Therapy (SBRT) in Patients with Operable Stage I Non-Small Cell Lung Cancer (NSCLC): Final Report Of RTOG-F3502 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Feng‐Ming Kong, Jinming Yu, James J. Dignam, (unknown), Chen Hu, Yun Xiao, (unknown), Andrew C. Chang, Mark B. Orringer, T. D’Amico, F Yin, Ning J. Yue, Weimin Mao, Kuaile Zhao, (unknown), (unknown), Mitchell Machtay	1
2	Quantitative perfusion assessment of gastric conduit with indocyanine green dye to predict anastomotic leak after esophagectomy 2021 ·Diseases of the Esophagus ·(unknown), Christopher Breuler, Andrew C. Chang, Jules Lin, Mark B. Orringer, William R. Lynch, Kiran H. Lagisetty, Elliot Wakeam, Rishindra M. Reddy	8
3	Similar Quality of Life After Conventional and Robotic Transhiatal Esophagectomy 2021 ·The Annals of Thoracic Surgery ·Aaron M. Williams, (unknown), Lili Zhao, Tyler R. Grenda, (unknown), Alexander A. Brescia, (unknown), Emily S. Barrett, Andrew C. Chang, William R. Lynch, Jules Lin, Elliot Wakeam, Kiran H. Lagisetty, Mark B. Orringer, Rishindra M. Reddy	6
4	A novel cervical esophagogastric anastomosis simulator 2020 ·Journal of Thoracic and Cardiovascular Surgery ·Mark B. Orringer, (unknown), Jules Lin, Deborah M. Rooney	8
5	Silencing of Long Noncoding RNA MIR22HG Triggers Cell Survival/Death Signaling via Oncogenes YBX1, MET, and p21 in Lung Cancer 2018 ·Cancer Research ·Wenmei Su, (unknown), Xiuyuan Chen, Xia Yang, Rui Mao, Chunfang Guo, Zhuwen Wang, Dafydd G. Thomas, Jules Lin, Rishindra M. Reddy, Mark B. Orringer, Andrew C. Chang, Zhixiong Yang, David G. Beer, Guoan Chen	119
6	Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers 2017 ·Cancer Research ·Vasudha Murlidhar, Rishindra M. Reddy, Shamileh Fouladdel, Lili Zhao, (unknown), Svetlana Grabauskiene, Zhuo Zhang, Jules Lin, Andrew C. Chang, Philip W. Carrott, William R. Lynch, Mark B. Orringer, Chandan Kumar‐Sinha, Nallasivam Palanisamy, David G. Beer, Max S. Wicha, Nithya Ramnath, Ebrahim Azizi, Sunitha Nagrath	139
7	Evaluation of acute and chronic pain outcomes after robotic, video-assisted thoracoscopic surgery, or open anatomic pulmonary resection 2017 ·Journal of Thoracic and Cardiovascular Surgery ·(unknown), Lili Zhao, Rishindra M. Reddy, Andrew C. Chang, Mark B. Orringer, Chad M. Brummett, Jules Lin	91
8	Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer 2017 ·PMC ·Feng‐Ming Kong, Randall K. Ten Haken, Matthew J. Schipper, Kirk A. Frey, James A. Hayman, Milton D. Gross, Nithya Ramnath, Khaled A. Hassan, M.M. Matuszak, (unknown), Nan Bi, Weili Wang, Mark B. Orringer, Kemp B. Cease, Theodore S. Lawrence, Gregory P. Kalemkerian	9
9	A MicroRNA Cluster at 14q32 Drives Aggressive Lung Adenocarcinoma 2014 ·Clinical Cancer Research ·Ernest Nadal, Jinjie Zhong, Jules Lin, Rishindra M. Reddy, Nithya Ramnath, Mark B. Orringer, Andrew C. Chang, David G. Beer, Guoan Chen	85
10	Decreased Selenium-Binding Protein 1 in Esophageal Adenocarcinoma Results from Posttranscriptional and Epigenetic Regulation and Affects Chemosensitivity 2010 ·Clinical Cancer Research ·Amy L. Silvers, Lin Lin, Adam J. Bass, Guoan Chen, Zhuwen Wang, Dafydd G. Thomas, Jules Lin, Thomas J. Giordano, Mark B. Orringer, David G. Beer, Andrew C. Chang	61
11	Autoantibody Profiles Reveal Ubiquilin 1 as a Humoral Immune Response Target in Lung Adenocarcinoma 2007 ·Cancer Research ·Guoan Chen, Xiaoju Wang, Jianjun Yu, Sooryanarayana Varambally, Jindan Yu, Dafydd G. Thomas, Mu-Yen Lin, Prakash Vishnu, Zhuwen Wang, Rui Wang, (unknown), Debashis Ghosh, Thomas J. Giordano, Donald Giacherio, Andrew C. Chang, Mark B. Orringer, Talal El‐Hefnawy, William L. Bigbee, David G. Beer, Arul M. Chinnaiyan	73
12	Awake Tracheobronchial Dilation Without the Use of Rigid Bronchoscopy 2006 ·The Annals of Thoracic Surgery ·Andrew C. Chang, Allan Pickens, Mark B. Orringer	2
13	Development of a CD-ROM internet hybrid: a new thoracic surgery curriculum 2002 ·The Annals of Thoracic Surgery ·Jeffrey P. Gold, (unknown), Gordon N. Olinger, Mark B. Orringer	11
14	ANTERIOR MEDIASTINAL TRACHEOSTOMY 1996 ·Chest Surgery Clinics of North America ·Mark B. Orringer	1
15	Amplification and over‐expression of the EGFR and erbB‐2 genes in human esophageal adenocarcinomas 1993 ·International Journal of Cancer ·Mazin Al‐Kasspooles, Jason H. Moore, Mark B. Orringer, David G. Beer	182
16	Sucrase-isomaltase gene expression in Barrett's esophagus and adenocarcinoma 1993 ·Gastroenterology ·Gary D. Wu, (unknown), Jason H. Moore, Mark B. Orringer, Henry D. Appelman, Peter G. Traber	41
17	Complications in cardiothoracic surgery 1991 ·John A. Waldhausen, Mark B. Orringer	34
18	Follicular carcinoma of the thyroid with massive angioinvasion: extension of tumor thrombus to the heart. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Norman W. Thompson, (unknown), Mark B. Orringer, James C. Sisson, Ronald H. Nishiyama	45
19	Collis-Belsey reconstruction of the esophagogastric junction 1976 ·Journal of Thoracic and Cardiovascular Surgery ·Mark B. Orringer, Herbert Sloan	38
20	Substernal gastric bypass of the excluded thoracic esophagus for palliation of esophageal carcinoma 1975 ·Journal of Thoracic and Cardiovascular Surgery ·Mark B. Orringer, Herbert Sloan	101

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact